Skip to main content
← back
Must-Read

AstraZeneca to Invest $2.5bn in China After Scandal

Update / Judgement Date

21 Mar 2025

Source

Financial Times

Author

Team — WCP Legal Desk

Reading Time

1 min read

Corporate Law & GovernanceFinancial ManagementMerger & Acquisition